Resources > Video
Alzheimer's Disease Research

Treating Early-Stage Alzheimer’s Disease: Newly Available Treatments and What They Mean for Patients

Join us for “Treating Early-Stage Alzheimer’s Disease: Newly Available Treatments and What They Mean for Patients.” This hour-long online session features two leading doctors, a representative from BrightFocus, and a person with AD who will help caregivers and patients understand newly approved therapies that treat Alzheimer’s disease (AD) itself, not just the symptoms.

Topics:

  1. What is early Alzheimer’s disease?
  2. How is Alzheimer’s different from normal aging?
  3. Why early diagnosis is important?
  4. New therapies for Alzheimer’s
  5. How new treatments work
  6. Choosing the right treatment for you or your loved one
  7. Shared decision-making with your care team

About BrightFocus Foundation

BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.

Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.

  • Treatments

Share this post